Global Drug Eluting Balloons (DEB) Competitive Landscape Professional Research Report 2025

Research Summary

Drug-eluting balloons (DEB) are medical devices used in interventional cardiology to treat narrowed or blocked blood vessels, typically in coronary arteries. These balloons are coated with a medication, usually an anti-proliferative drug, that is released into the vessel wall when the balloon is inflated. When the DEB is positioned at the site of the blockage and inflated, the drug is delivered to the tissue, helping to prevent restenosis (re-narrowing) of the vessel by inhibiting excessive cell growth. DEBs offer a localized and targeted drug delivery approach, combining the mechanical benefits of angioplasty with the therapeutic effects of drug therapy. They are commonly used as an alternative to drug-eluting stents in certain cases and are effective in improving the outcomes of patients undergoing vascular interventions.

According to DIResearch's in-depth investigation and research, the global Drug Eluting Balloons (DEB) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Drug Eluting Balloons (DEB) include B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotech, Philips, Aachen Resonance, Eurocor, Biotronic etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Drug Eluting Balloons (DEB). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drug Eluting Balloons (DEB) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drug Eluting Balloons (DEB) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug Eluting Balloons (DEB) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Drug Eluting Balloons (DEB) Include:

B. Braun

Medtronic

Boston Scientific

BD

Yinyi Biotech

Philips

Aachen Resonance

Eurocor

Biotronic

Drug Eluting Balloons (DEB) Product Segment Include:

Peripheral DEBs

Coronary DEBs

Drug Eluting Balloons (DEB) Product Application Include:

Catheterization Laboratory

Hospital

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Drug Eluting Balloons (DEB) Industry PESTEL Analysis

Chapter 3: Global Drug Eluting Balloons (DEB) Industry Porter’s Five Forces Analysis

Chapter 4: Global Drug Eluting Balloons (DEB) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Drug Eluting Balloons (DEB) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Drug Eluting Balloons (DEB) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Drug Eluting Balloons (DEB) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Drug Eluting Balloons (DEB) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Drug Eluting Balloons (DEB) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Drug Eluting Balloons (DEB) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Drug Eluting Balloons (DEB) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Drug Eluting Balloons (DEB) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources